The FY2025 (Dec) proxy of Travere Therapeutics names 23 peer companies for pay. Among Travere Therapeutics and these peers, CEO pay was 6th highest of 9 and total shareholder return was 5th highest of 9.
6th highest of 9in Travere Therapeutics and its pay peers, FY2025 (Dec) by CEO pay:
$1.7M$23.3M
5th highest of 9in Travere Therapeutics and its pay peers, FY2025 (Dec) by total shareholder return:
$17$523
Pay peer group, FY2025 (Dec) proxy
| PTC Therapeutics | ||
| Supernus Pharmaceuticals | ||
| INSMED | ||
| Ultragenyx Pharmaceutical | ||
| Mirum Pharmaceuticals | ||
| Harmony Biosciences Holdings | ||
| Agios Pharmaceuticals | ||
| Collegium Pharmaceutical | ||
| Amicus Therapeutics | Not disclosed | Not disclosed |
| Biocryst Pharmaceuticals | Not disclosed | Not disclosed |
| Coherus BioSciences (now known as Coherus Oncology) | Not disclosed | Not disclosed |
| Corcept Therapeutics | Not disclosed | Not disclosed |
| Dynavax Technologies | Not disclosed | Not disclosed |
| Intercept Pharmaceuticals | Not disclosed | Not disclosed |
| Ironwood Pharmaceuticals | Not disclosed | Not disclosed |
| Ligand Pharmaceuticals | Not disclosed | Not disclosed |
| PHAT | Not disclosed | Not disclosed |
| Pacira BioSciences | Not disclosed | Not disclosed |
| Phathom Pharmaceuticals | Not disclosed | Not disclosed |
| Rhythm Pharmaceuticals | Not disclosed | Not disclosed |
| Vanda Pharmaceuticals | Not disclosed | Not disclosed |
| Vericel | Not disclosed | Not disclosed |
| Xeris Biopharma Holdings | Not disclosed | Not disclosed |
23 companies
Changes by year
FY2025 (Dec) proxy
- AddedPHATpay peer group
- AddedXeris Biopharma Holdingspay peer group
- RemovedDCPHpay peer group
- RemovedDeciphera Pharmaceuticalspay peer group
- RemovedICPTpay peer group
- RemovedINSMEDpay peer group
- RemovedVNDApay peer group
FY2024 (Dec) proxy
- AddedBiocryst Pharmaceuticalspay peer group
- AddedDCPHpay peer group
- AddedHarmony Biosciences Holdingspay peer group
- AddedMirum Pharmaceuticalspay peer group
- AddedRhythm Pharmaceuticalspay peer group
- RemovedArrowhead Pharmaceuticalspay peer group
- RemovedArrowhead Pharmaceuticalspay peer group
- RemovedEGRXpay peer group
- RemovedENTApay peer group
- RemovedEagle Pharmaceuticals Incpay peer group
- RemovedEnanta Pharmaceuticalspay peer group
- RemovedIMGNpay peer group
- RemovedImmunoGenpay peer group
- RemovedSRNEpay peer group
- RemovedSorrento Therapeuticspay peer group
FY2023 (Dec) proxy
- AddedArrowhead Pharmaceuticalspay peer group
- AddedDVAXpay peer group
- AddedIRWDpay peer group
- AddedUltragenyx Pharmaceuticalpay peer group
- RemovedANIKpay peer group
- RemovedAnika Therapeuticspay peer group
- RemovedFLXNpay peer group
- RemovedFlexion Therapeuticspay peer group
- RemovedHRTXpay peer group
- RemovedHeron Therapeuticspay peer group
- RemovedOMERpay peer group
- RemovedOmeros Corportationpay peer group
- RemovedRIGLpay peer group
- RemovedRigel Pharmaceuticalspay peer group
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.